%0
Generic
%T
Optimal dosing of a glycoprotein IIb/IIIa antagonist with a simplified renal-based algorithm: Pharmacodynamic and clinical findings from PARAGON B Christopher K. Dyke, Kenneth W. Mahaffey, Lisa G. Berdan, Magnus Ohman, Kristin Newby, Rodney A. Sparapani, Peter B. Berger, Neal S. Kleiman, Harvey D. White, Judith S. Hochman, Frans van de Werf, Paul W. Armstrong, Robert M. Califf, Robert A. Harrington, Eric J. Topol. Duke Clinical Research Institute, Durham, NC
%I Elsevier BV
%@ 0735-1097
%K Cardiology and Cardiovascular Medicine
%D 2001
%C Elsevier BV
%U http://slubdd.de/katalog?TN_libero_mab2